Furthermore, genetic ablation of JARID1A/RBP2 decreased tumor formation in the pancreatic islets of Men1 (a tumor suppressor)-defective mice and in the pituitary glands of Rb(+/−) mice, thereby improving the survival of these mice. The gene discussed is MEN1; the disease is neoplasm.